Literature DB >> 11445643

Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients.

P Sarchielli1, A Alberti, A Floridi, V Gallai.   

Abstract

Nerve growth factor (NGF) levels were determined in the CSF of patients with chronic daily headache (CDH) and correlated with levels of sensory neuropeptides. Patients with CDH showed higher NGF levels in the CSF compared with control subjects (p < 0.0001). Higher CSF levels of substance P (SP) (p < 0.002) and calcitonin-gene-related peptide (CGRP) (p < 0.0001) were also found. There was a significant positive correlation between NGF and both SP and CGRP values. These findings suggest that NGF is involved in the long-lasting sensitization and sustained activation of the trigeminal system in CDH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445643     DOI: 10.1212/wnl.57.1.132

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 2.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

Review 3.  Sensitization, glutamate, and the link between migraine and fibromyalgia.

Authors:  Paola Sarchielli; Massimiliano Di Filippo; Katiuscia Nardi; Paolo Calabresi
Journal:  Curr Pain Headache Rep       Date:  2007-10

4.  Effects of NGF-induced muscle sensitization on proprioception and nociception.

Authors:  Peter Svensson; Kelun Wang; Lars Arendt-Nielsen; Brian E Cairns
Journal:  Exp Brain Res       Date:  2008-05-14       Impact factor: 1.972

Review 5.  Approach to chronic daily headache.

Authors:  Huma U Sheikh
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

6.  Headache in Petrous Apicitis: A Case Report of Chronic Migraine-like Headache Due to Peripheral Pathology.

Authors:  Alyssa J Mancini; Rebecca D Glassman; Yu-Ming Chang; Rami Burstein; Sait Ashina
Journal:  Headache       Date:  2019-09-18       Impact factor: 5.887

Review 7.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

Review 8.  Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.

Authors:  Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Neurobiol       Date:  2008-05-06       Impact factor: 5.590

9.  Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans.

Authors:  Helle Andersen; Lars Arendt-Nielsen; Peter Svensson; Bente Danneskiold-Samsøe; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2008-09-24       Impact factor: 1.972

10.  Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons.

Authors:  Paul L Durham; Andrew F Russo
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.